NEWPORT MEDICAL INSTRUMENTS, INC. – Trademark Portfolio
Entity Type: 03
NEWPORT MEDICAL INSTRUMENTS, INC. holds 17 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 13 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 2 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include HT70, NEWPORT, HT70 PLUS, NEWPORT HT70, and NEWPORT HT70 PLUS. The owner is based in NEWPORT BEACH, CA.
300 N. NEWPORT BLVD.
NEWPORT BEACH, CA 92663
Showing of trademarks Trademarks
Trademark Classifications
NEWPORT MEDICAL INSTRUMENTS, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does NEWPORT MEDICAL INSTRUMENTS, INC. have?
NEWPORT MEDICAL INSTRUMENTS, INC. has 17 U.S. trademarks filed with the USPTO. Of these, 5 registered, 3 abandoned, 9 cancelled.
What trademark classes does NEWPORT MEDICAL INSTRUMENTS, INC. file in?
NEWPORT MEDICAL INSTRUMENTS, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 9 (Computers & Electronics). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are NEWPORT MEDICAL INSTRUMENTS, INC.'s most well-known trademarks?
NEWPORT MEDICAL INSTRUMENTS, INC.'s registered trademark portfolio includes well-known marks such as HT70, NEWPORT, HT70 PLUS, NEWPORT HT70, and NEWPORT HT70 PLUS. These are among 5 currently registered trademarks in the portfolio.
What is NEWPORT MEDICAL INSTRUMENTS, INC.'s trademark registration success rate?
NEWPORT MEDICAL INSTRUMENTS, INC. has a 29% trademark registration rate, with 5 out of 17 resolved applications resulting in successful registration. Currently, 0 applications are pending review.